Metabolism Select  by unknown
Leading Edge
Metabolism Select
The role of adipose tissue, or fat, in the development and treatment of metabolic disease is the subject of this issue’s
Select. A cluster of new studies in mice suggest that dysregulation of lymphocytes and other inflammatory cells in
adipose tissue contributes to obesity and metabolic diseases such as type 2 diabetes. Elucidation of how the inflamma-
tory response affects different types of adipose tissue may shed light on new strategies for treating diseases associated
with obesity.
T Cells Send Fat a Mixed Message
The increase in metabolic diseases worldwide has been linked to a spike in obesity. Chronic inflammation of adipose tissue is
known to be associated with obesity and to contribute to insulin resistance, a major feature of metabolic diseases, but how
this process begins is unclear. Three recent papers (Feuerer et al., 2009; Winer et al., 2009; Nishimura et al., 2009) now
address this issue.
Do T Cells Fight Flab?
Given the role of CD4+ regulatory T cells (Tregs) in controlling inappropriate immune responses, Feuerer et al. (2009) examine
the part played by these cells in the inflammatory response in adipose tissue from leanmice. They find that Tregs are enriched
in visceral adipose tissue (VAT), but not in subcutaneous adipose tissue (SAT) or other tissues. They also analyze obese mice
and observe a strong correlation between insulin resistance and a lower proportion of Tregs in VAT but not other tissues.
Systemic depletion of Tregs in mice induces the expression of genes encoding proinflammatory cytokines mainly in VAT,
and triggers insulin resistance. On the other hand, expansion of Tregs in vivo leads to lower blood glucose concentrations
and reduced glucose intolerance in mice fed a high-fat diet. Thus Tregs appear to protect against excessive inflammation
of VAT andmay block progression tometabolic disease. Tregs produce the cytokine interleukin-10, which inhibits the expres-
sion of proinflammatory mediators from adipocytes. Hence, this Treg-derived cytokine may directly regulate adipocyte func-
tion in VAT.
In a related study, Winer et al. (2009) assess the broader CD4+ T lymphocyte population in VAT. The authors examine T cell
populations from both SAT and VAT of obese and lean mice and observe increased numbers of CD4+ T cells after diet-
induced obesity. Within the CD4+ T cell population, the authors find a rising bias toward proinflammatory T helper 1 (Th1) cells
relative to Tregs in VAT from obese humans andmice, which appears to be antigen-driven. They find that mutant mice lacking
lymphocytes and fed a high-fat diet aremore prone to weight gain and developing insulin resistance thanwild-typemice, sug-
gesting that T lymphocytes may be important regulators of metabolism. Further, when these mutant mice are reconstituted
with CD4+ T cells, they display less weight gain, lower serum levels of obesity-associated adipokines such as leptin, normal-
ized glucose tolerance, and improved insulin sensitivity in response to a high-fat diet. Through additional cellular reconstitu-
tion and depletion experiments, the investigators demonstrate that it is the Tregs together with anti-inflammatory T helper
2 cells that help to control obesity and the development of insulin resistance until overwhelmed by expanding Th1 cells.
Immunotherapy that decreases the ratio of Th1 cells to Tregs in VAT results in long-lasting improved glucose tolerance of
mice fed a high-fat diet.
But is the decrease in Treg proportions in the VAT of obese mice a cause or consequence of inflammation? Regardless, an
upstream initiating event must trigger their loss. The nature of such an event is unclear, but it could be associated with
hypoxia, or adipocyte stress or death. The studies establish a role for the adaptive immune system in reducing adipose tissue
inflammation and insulin resistance and also suggest that stimulation of CD4+ T cells by autoantigen may contribute to the
accumulation of these cells in VAT. If so, identifying the antigenic epitopes in VAT may enable development of a vaccine
against metabolic diseases like type 2 diabetes.
Initiating Inflammation and Insulin Resistance
But why is there an inflammatory response in adipose tissue in the
first place? Nishimura et al. (2009) address this question in their
new study. They also analyze immune cell populations from the
VAT of obese and lean mice to identify local immunological
changes induced by obesity. Along with an increase in macro-
phages, they observe that the CD8+ T cell fraction is elevated in
the VAT of obese mice. In contrast, the CD8+ T cell counts are
the same or lower in other tissues from obese mice compared to
lean mice, suggesting that CD8+ T cells are selectively recruited
to the VAT of obese animals. The authors perform a time course
to evaluate the changes in immune cell populations during the
progression of diet-induced obesity in the mice. They find that
the increase in CD8+ T cells in VAT occurs prior to the accumula-
tion of macrophages or the reduction in Tregs. Further, whereas
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systemic depletion of the CD8+ T cell population has no effect on body weight or food intake in mice fed a high-fat diet, it does
reduce the infiltration of macrophages in VAT, lowers production of proinflammatory cytokines, and ameliorates the insulin
resistance and glucose intolerance induced by the high-fat diet. The authors also show that CD8+ T cells and adipose tissue
cooperate to induce macrophage differentiation and activation, thus initiating an inflammatory cascade. Further studies may
reveal what cues within obese VAT initiate the accumulation of CD8+ T cells and whether this accumulation plays a part in the
reduction of Tregs in the VAT of obese animals.
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WAT’s UP with Mast Cells?
The white adipose tissue (WAT) of mammals is known to contain
macrophages and lymphocytes, but according to new work by
Liu et al. (2009), it also harbors mast cells. These inflammatory
cells are important not only in wound healing, allergy, and autoim-
mune disease, but also, as Liu et al. elegantly demonstrate, in
obesity and diabetes. The authors find that there are more mast
cells in WAT from obese humans and animals than from lean
subjects. Further, when fed a high-fat diet, mice lacking mast cells
have less total fat, lower body weight, increased glucose toler-
ance, and increased insulin sensitivity compared to wild-type
mice. Pharmacological inhibition of mast cell activation has
the same effect on metabolism, and more interestingly also
reverses pre-established obesity and diabetes in mice fed a high-fat diet. The authors find that a lack of mast cells or their
inactivation reduces blood vessel formation (angiogenesis) in WAT and hence formation of more adipose tissue. Indeed,
they provide evidence that the mast cell-derived cytokines interleukin-6 and interferon-g contribute to angiogenesis by
stimulating cysteine protease cathepsin production by adipocytes, which leads to the release of proangiogenic peptides.
These findings suggest that allergy drugs, which combat mast cell activity, may provide a new therapeutic approach for
treating obesity.
Liu et al. (2009). Nat. Med. 15, 940–945.
When the Good Twin Wins
White adipose tissue (WAT), which stores energy as triglycerides, has a good twin,
brown adipose tissue (BAT), which releases energy in the form of heat. In new
work, Kajimura et al. (2009) reveal how to make BAT. The transcriptional regulator
PRDM16 is known to control the switch between brown fat formation and muscle
cell differentiation from a common precursor cell. Using a proteomics approach,
the authors now isolate factors that cooperate with PRDM16 to regulate this devel-
opmental switch. They identify the transcription factor C/EBP-b as a critical binding
partner in the PRDM16 transcriptional complex and show that it is required for
PRDM16 to convert immature muscle cells into brown adipocytes. Surprisingly,
the two factors are sufficient to induce the expression of brown fat-specific genes
by mouse embryonic fibroblasts (MEFs), causing them to differentiate into adipo-
cytes. Indeed, when transplanted into mice, MEFs expressing both factors form
ectopic fat pads with the characteristics of BAT. For instance, by monitoring glucose
uptake with positron emission tomography, the authors show that the engineered
BAT acts like a sink for active disposal of glucose. This pathway might offer a new
strategy to counteract obesity and metabolic disease by using BAT to dissipate
stored energy.
Kajimura et al. (2009). Nature. 460, 1154–1158.
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